Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300206 · ClinicalTrials.gov registry record
A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
A clinical trial of Breast Cancer Female, sponsored by Hologic.
- Completed
- Registry status
- 525
- Enrollment target
- 7
- Study locations
NCT03300206 is a study of Breast Cancer Female that has completed, run by Hologic. The registered enrollment target is 525 participants, below the 681-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (23% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT03300206, a study of Breast Cancer Female, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- 525 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current standard-of-care breast biopsy procedures
Conditions Studied
Interventions
- DEVICE Breast Biopsy
Study Locations (7)
Arizona
- HonorHealth - Phoenix
Maryland
- Kensington Medical Center - Kaiser Permanente - Kensington
Missouri
- Washington University - St Louis
New York
- Elizabeth Wende Breast Center - Rochester
Pennsylvania
- Magee-Womens Hospital of UPMC - Pittsburgh
Texas
- MD Anderson Cancer Center - Houston
Utah
- University of Utah - Huntsman Cancer Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2019-03-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300206
The ClinicalTrials.gov registry entry for NCT03300206 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 681-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (23% lower). The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 1 intervention - of which Breast Biopsy is the first listed.
NCT03300206 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arizona, Maryland, Missouri.
Frequently Asked Questions
What is clinical trial NCT03300206 about?
NCT03300206 is a clinical study titled "A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System". The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current...
What is the current status of trial NCT03300206?
This trial is currently completed. The enrollment target is 525 participants. The study started on 2017-09-13. Estimated completion is 2019-03-19.
What conditions does trial NCT03300206 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT03300206?
The interventions under investigation include: Breast Biopsy (DEVICE).
Who is sponsoring clinical trial NCT03300206?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03300206 being conducted?
This trial has 7 study locations across Arizona, Maryland, Missouri, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.